Skip to main content
. 2023 Sep 20;26:100599. doi: 10.1016/j.lana.2023.100599

Table 1.

Comparison of patient, hospital and outcome characteristics across different DBS-cohorts.

PD ET Dystonia PD-DBS ET-DBS Dystonia-DBS P
Age (year) 76.57 ± 9.74
n = 752,225
72.87 ± 12.79
n = 172,480
55.36 ± 22.59
n = 73,005
65.11 ± 8.93
n = 8655
67.57 ± 10.61
n = 3690
53.68 ± 18.95
n = 1270
<0.001; Post-hoc
PD-ET∗∗∗
PD-Dystonia∗∗∗
ET-Dystonia∗∗∗
Female n (%) 314,700 (41.8)
n = 752,040
93,560 (54.3)
n = 172,430
43,405 (59.4)
n = 73,060
2640 (30.5)∗∗∗n = 8650 1645 (44.6)∗∗∗n = 3685 700 (55.1)∗∗∗n = 1270 <0.001
Race, n (%) n = 726,835 n = 164,760 n = 69,520 n = 8260 n = 3420 n = 1175 <0.001
 White 582,185 (80.1) 148,520 (90.1) 49,270 (70.9) 7020 (85.0)∗∗∗ 3220 (94.2)∗∗∗ 1010 (86.0)
 African American 50,735 (7.0) 6590 (4.0) 10,855 (15.6) 145 (1.8) 45 (1.3) 20 (1.7)
 Hispanic 55,790 (7.7) 5440 (3.3) 5845 (8.4) 565 (6.8)∗∗ 75 (2.2)∗∗∗ 80 (6.8)
 Asian or Pacific Islander 17,900 (2.5) 1365 (0.8) 1330 (1.9) 215 (2.6)∗ 25 (0.7) 15 (1.3)
 Native American 2515 (0.3) 405 (0.2) 420 (0.6) 35 (0.4) 0 5 (0.4)
 Other 17,710 (2.4) 2440 (1.5) 1800 (2.6) 280 (3.4) 55 (1.6) 45 (3.8)
Median household income for patient's zip code, n (%) n = 741,145 n = 170,130 n = 71,510 n = 8480 n = 3625 n = 1240 <0.001
 Quartile 1: 1–47,999$ 193,165 (26.1) 37,225 (21.9) 22,030 (30.8) 1370 (16.2) 780 (21.5)∗∗ 180 (14.5)
 Quartile 2: 48,000–60,999$ 192,115 (25.9) 46,945 (27.6) 18,275 (25.6) 2165 (25.5) 1045 (28.8) 365 (29.4)
 Quartile 3: 61,000–81,999$ 183,315 (24.7) 45,900 (27.0) 16,840 (23.5) 2295 (27.1) 1010 (27.9) 305 (24.6)
 Quartile 4: 82,000+ $ 172,550 (23.3) 40,060 (23.5) 14,365 (20.1) 2650 (31.2)∗∗ 790 (21.8)∗∗∗ 390 (31.5)
Primary expected payer, n (%) n = 751,545 n = 172,235 n = 72,985 n = 8650 n = 3675 n = 1270 <0.001
 Medicare 656,080 (87.3) 135,945 (78.9) 40,920 (56.1) 5565 (64.3) 2610 (71.0)∗∗∗ 610 (48.0)∗∗∗
 Medicaid 23,965 (3.2) 7715 (4.5) 14,465 (19.8) 195 (2.3)∗∗∗ 115 (3.1) 125 (9.8)∗∗∗
 Private insurance 55,770 (7.4) 23,990 (13.9) 14,015 (19.2) 2555 (29.5) 785 (21.4)∗∗∗ 510 (40.2)∗∗∗
 Self-pay 3655 (0.5) 1635 (0.9) 1500 (2.1) 50 (0.6) 15 (0.4) 0
 No charge 295 (0) 140 (0.1) 145 (0.2) 0 0 0
 Other 11,780 (1.6) 2810 (1.6) 1940 (2.7) 285 (3.3) 150 (4.1) 25 (2.0)
Patient location: NCHS urban-rural code, n (%) n = 750,680 n = 172,065 n = 72,535 n = 8605 n = 3685 n = 1260 <0.001
 "Central" counties of metro areas of ≥1 million population 209,930 (28.0) 41,235 (24.0) 22,215 (30.6) 2310 (26.8)∗ 730 (19.8)∗∗ 320 (25.4)
 "Fringe" counties of metro areas of ≥1 million population 193,460 (25.8) 43,850 (25.5) 16,815 (23.2) 2260 (26.3) 820 (22.3) 325 (25.8)
 Counties in metro areas of 250,000–999,999 population 146,825 (19.6) 37,075 (21.5) 15,755 (21.7) 1785 (20.7) 855 (23.2) 245 (19.4)
 Counties in metro areas of 50,000–249,999 population 72,545 (9.7) 19,805 (11.5) 6900 (9.5) 910 (10.6) 470 (12.8) 185 (14.7)
 Micropolitan counties 72,305 (9.6) 17,400 (10.1) 6260 (8.6) 790 (9.2) 485 (13.2)∗ 80 (6.3)
 Not metropolitan or micropolitan counties 55,615 (7.4) 12,700 (7.4) 4590 (6.3) 550 (6.4) 325 (8.8) 105 (8.3)
Census division of hospital, n (%) n = 752,245 n = 172,485 n = 73,080 n = 8655 n = 3690 n = 1270 <0.001
 New England 37,255 (5.0) 8760 (5.1) 4265 (5.8) 280 (3.2) 90 (2.4) 70 (5.5)
 Middle Atlantic 116,560 (15.5) 19,495 (11.3) 9370 (12.8) 1245 (14.4)∗∗ 345 (9.3)∗ 125 (9.8)
 East North Central 124,705 (16.6) 33,180 (19.2) 12,180 (16.7) 1160 (13.4) 515 (14.0) 125 (9.8)
 West North Central 52,795 (7.0) 17,660 (10.2) 6465 (8.8) 775 (9.0) 450 (12.2) 180 (14.2)
 South Atlantic 150,460 (20.0) 33,080 (19.2) 15,100 (20.7) 1500 (17.3) 670 (18.2) 280 (22.0)
 East South Central 50,460 (6.7) 9840 (5.7) 4240 (5.8) 375 (4.3) 210 (5.7) 85 (6.7)
 West South Central 81,680 (10.9) 13,780 (8.0) 7210 (9.9) 915 (10.6) 425 (11.5) 100 (7.9)
 Mountain 39,095 (5.2) 12,440 (7.2) 4765 (6.5) 855 (9.9) 460 (12.5) 95 (7.5)
 Pacific 99,235 (13.2) 24,250 (14.1) 9485 (13.0) 1550 (17.9) 525 (14.2) 210 (16.5)
Bed size of hospital, n (%) n = 752,245 n = 172,485 n = 73,080 n = 8655 n = 3690 n = 1270 0.3
 Small 158,775 (21.1) 34,025 (19.7) 13,345 (18.3) 325 (3.8) 140 (3.8) 55 (4.3)
 Medium 225,320 (30.0) 47,450 (27.5) 19,970 (27.3) 1285 (14.8) 675 (18.3) 200 (15.7)
 Large 368,150 (48.9) 91,010 (52.8) 39,765 (54.4) 7045 (81.4) 2875 (77.9) 1015 (79.9)
Location/teaching status of hospital, n (%) n = 752,245 n = 172,485 n = 73,080 n = 8655 n = 3690 n = 1270 0.09
 Rural 84,025 (11.2) 17,475 (10.1) 5815 (8.0) 45 (0.5) 25 (0.7) 0
 Urban nonteaching 209,235 (27.8) 42,385 (24.6) 14,870 (20.3) 355 (4.1) 170 (4.6) 15 (1.2)
 Urban teaching 458,985 (61.0) 112,625 (65.3) 52,395 (71.7) 8255 (95.4) 3495 (94.7) 1255 (98.8)
Control/ownership of hospital, n (%) n = 752,245 n = 172,485 n = 73,080 n = 8655 n = 3690 n = 1270 0.28
 Government, non-federal 75,255 (10.0) 16,895 (9.8) 9085 (12.4) 1275 (14.7) 570 (15.4) 140 (11.0)
 Private, not-for-profit 557,420 (74.1) 137,685 (79.8) 54,970 (75.2) 6925 (80.0) 2965 (80.4) 1080 (85.0)
 Private, investor-owned 119,570 (15.9) 17,905 (10.4) 9025 (12.3) 455 (5.3) 155 (4.2) 50 (3.9)
All patient refined DRG: risk of mortality subclass, n (%) n = 752,135 n = 172,470 n = 72,995 n = 8655 n = 3690 n = 1270 <0.001
 Minor likelihood of dying 81,150 (10.8) 46,000 (26.7) 29,350 (40.2) 7575 (87.5)∗∗ 2965 (80.4)∗∗∗ 1120 (88.2)
 Moderate likelihood of dying 293,125 (39.0) 61,105 (35.4) 21,565 (29.5) 895 (10.3)∗ 605 (16.4)∗∗∗ 120 (9.4)
 Major likelihood of dying 278,675 (37.0) 50,200 (29.1) 15,750 (21.6) 115 (1.3) 80 (2.2) 25 (2.0)
 Extreme likelihood of dying 99,185 (13.2) 15,165 (8.8) 6330 (8.7) 70 (0.8) 40 (1.1) 5 (0.4)
All patient refined DRG: severity of illness subclass, n (%) n = 752,135 n = 172,470 n = 72,995 n = 8655 n = 3690 n = 1270 <0.001
 Minor loss of function (includes cases with no comorbidity or complications) 49,790 (6.6) 25,310 (14.7) 7610 (10.4) 6335 (73.2)∗∗∗ 2330 (63.1)∗∗∗ 805 (63.4)
 Moderate loss of function 285,175 (37.9) 68,805 (39.9) 30,910 (42.3) 2075 (24.0)∗∗∗ 1200 (32.5)∗∗∗ 380 (29.9)
 Major loss of function 317,470 (42.2) 62,900 (36.5) 26,175 (35.8) 200 (2.3) 120 (3.3) 65 (5.1)
 Extreme loss of function 99,700 (13.3) 15,455 (9.0) 8300 (11.4) 45 (0.5) 40 (1.1) 20 (1.6)
Outcomes
 Length of stay (days) 5.80 ± 7.03
n = 752,120
5.15 ± 6.01
n = 172,470
8.42 ± 13.64
n = 73,075
1.69 ± 1.97
n = 8655
1.59 ± 1.81
n = 3690
2.54 ± 9.68
n = 1270
0.17
 Total charges (USD, 2015–2017) 52,729 ± 69,215
n = 745,650
51,923 ± 64,255
n = 169,605
65,948 ± 139,356
n = 72,155
101,494 ± 72,268
n = 8500
94,212 ± 60,176
n = 3665
111,139 ± 154,242
n = 1265
0.02; Post-hoc
NS
 Inpatient mortality (%) 26,420 (3.5)
n = 750,985
2945 (1.7)
n = 172,335
930 (1.3)
n = 72,990
0
n = 8650
5 (0.1)
n = 3685
0
n = 1270
0.26
Disposition of patient, n (%) n = 750,985 n = 172,335 n = 72,990 n = 8650 n = 3685 n = 1270 <0.01
 Routine 201,010 (26.7) 78,950 (45.8) 38,080 (52.2) 7330 (84.7)∗ 3275 (88.9) 1125 (88.6)
 Transfer to short-term hospital 16,410 (2.2) 3010 (1.7) 1945 (2.7) 0 0 5 (0.4)∗
 Transfer other: includes skilled nursing facility (SNF), intermediate care facility (ICF), another type of facility 352,440 (46.9) 51,570 (29.9) 20,820 (28.5) 485 (5.6) 195 (5.3) 60 (4.7)
 Home health care (HHC) 151,410 (20.1) 34,905 (20.3) 10,525 (14.4) 835 (9.7)∗∗ 210 (5.7)∗ 80 (6.3)
 Against medical advice (AMA) 3720 (0.5) 935 (0.5) 680 (0.9) 0 0 0
 Died 26,420 (3.5) 2945 (1.7) 930 (1.3) 0 5 (0.1) 0
 Discharge alive, destination unknown 205 (0) 20 (0) 10 (0) 0 0 0

The columns labeled PD, ET, and dystonia represent the data of admissions for all patients diagnosed with Parkinson's Disease (PD), Essential Tremor (ET), and dystonia, respectively. In contrast, the columns labeled PD-DBS, ET-DBS, and dystonia-DBS specifically indicate admissions within the specified disease cohorts that underwent deep brain stimulation (DBS) implantation procedures during the corresponding admission period.

The values in each cell represent the exact count and proportion of the specified characteristic within the given cohort, unless noted otherwise. “The total number of discharges” is presented as an exact count (n), while the “age”, “length of stay” and “total charges” are presented as mean ± standard deviation.

Statistical analysis was only conducted among DBS cohorts to compare the proportion of the given characteristic in a specified cohort (i.e., the PD-DBS cohort) with the proportion of that characteristic in the entire patient population (i.e., all DBS-implanted patients).

The statistical significance of the results is indicated as follows: ∗∗∗ represents a P-value <0.001, ∗∗ represents a P-value <0.01, and ∗ represents a P-value <0.05.